Task force recommends clinicians offer high-risk patients pill to prevent HIV
The U.S. Preventive Services Task Force yesterday issued a draft recommendation that clinicians offer pre-exposure prophylaxis (PrEP), a daily pill that helps prevent HIV, to people at high risk for HIV. The task force also continued to recommend that clinicians screen all Americans aged 15 to 65 and pregnant women for HIV, as well as younger adolescents and older adults at increased risk for the virus. The panel will accept comments on the draft recommendations through Dec. 26.
Related News Articles
Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
The Centers for Disease Control and Prevention Aug. 11 released a health advisory on the risk of severe arboviral disease among patients receiving B-cell-…